Abivax (ABVX) Other Non-Current Assets (2022 - 2025)
Abivax's (ABVX) quarterly Other Non-Current Assets came in at $727527.2 in Q4 2025, down 88.5% year-on-year from $6.3 million in Q4 2024, and down 19.39% quarter-over-quarter from $902516.8 in Q1 2025.
Abivax (ABVX) Other Non-Current Assets (2022 - 2025) Analysis & Trends
Abivax's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $727527.2 for Q4 2025.
- On a quarterly basis, Other Non-Current Assets fell 88.5% year-over-year to $727527.2 in Q4 2025; TTM through Dec 2025 was $727527.2, a 88.5% decrease from a year earlier, with the FY2025 full-year figure at $727527.2, down 88.64% from the prior year.
- Other Non-Current Assets fell to $727527.2 in Q4 2025 per ABVX's latest filing, from $902516.8 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $6.3 million in Q4 2024 and bottomed at $727527.2 in Q4 2025.
- The 4-year median for Other Non-Current Assets is $1.1 million (2022), against an average of $2.1 million.
- Across the five-year window, Other Non-Current Assets soared 153.39% in 2024 and tumbled 88.5% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.1 million in 2022, then jumped by 135.93% to $2.5 million in 2023, then surged by 153.39% to $6.3 million in 2024, then tumbled by 88.5% to $727527.2 in 2025.
- Per Business Quant, the three latest ABVX Other Non-Current Assets figures stand at $727527.2 (Q4 2025), $902516.8 (Q1 2025), and $6.3 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 14.48 Mn |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 727,527.20 |
| Mar 31, 2025 | 902,516.85 |
| Dec 31, 2024 | 6.33 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | 1.06 Mn |